Weight Loss - Page 15

Ozempic users report surprising cravings for certain smells: Here's what to know

The rising trend of sweet-smelling gourmand fragrances coincides with anecdotal reports from GLP-1 weight-loss drug users experiencing new cravings for sugary scents.

Is Ozempic ruining your teeth? What to know about impact on dental health

Patients have reported dental issues like tooth decay and dry mouth after taking GLP-1s like Ozempic for weight loss, though no scientific evidence confirms this connection.

Scientists may have discovered why the pounds come back after losing weight

Experts highlight the complex mix of genetics, biology and environment in obesity. Study shows fat cells' memory affects metabolism and weight management.

Dr. Mike answers his followers' biggest health questions

Influencer and physician Dr. Mike Varshavski discusses benefits and drawbacks to using weight loss drugs while answering questions from his followers. 

Zone 2 training: The trending workout that burns fat without intense exercise

Zone 2 training is a fitness method that targets 60% to 70% of one's maximum heart rate, and maximizes fat burning compared to more strenuous exercise.

Study directly compares Zepbound and Wegovy for weight-loss results

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Weight-loss medications may also benefit common medical problem, study finds

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an unexpected secondary benefit revealed in recent studies.

Weight loss, diabetes drugs can cause mood changes: What to know about behavioral side effects

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.

Weight-loss drugs’ impact on cancer risk revealed in new study

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 RAs may help prevent the disease.

Semaglutide found to have shocking benefit for liver disease patients in new study

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.